EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.
← All Condition GuidesCLAIM RECON INTEL
Sarcoidosis VA Disability Rating
DC 6846 | 38 C.F.R. § 4.97 | M21-1, Part IV.ii.2.C
OVERVIEW
Sarcoidosis is rated under DC 6846 at 38 C.F.R. § 4.97. It is a multisystem granulomatous disease most commonly affecting lungs and lymph nodes. Veterans may develop sarcoidosis from occupational exposures during service (silica, beryllium, organic dusts) or from deployment airborne hazards (burn pits). Ratings based on pulmonary involvement and corticosteroid requirements.
RATING CRITERIA (4 LEVELS)
100% — Cor pulmonale, cardiac involvement with CHF, or progressive disease with systemic symptoms
Cor pulmonale; OR cardiac involvement with congestive heart failure; OR progressive pulmonary disease with fever, night sweats, and weight loss despite treatment.
60% — Systemic high-dose corticosteroids required
Pulmonary involvement requiring systemic high-dose (therapeutic) corticosteroids for control.
30% — Chronic low-dose or intermittent corticosteroids
Pulmonary involvement with persistent symptoms requiring chronic low-dose (maintenance) or intermittent corticosteroids.
10% — Stable, asymptomatic hilar adenopathy or lung infiltrates
Chronic hilar adenopathy or stable lung infiltrates without symptoms or physiologic impairment.
KEY EVIDENCE TO GATHER
-Biopsy-confirmed granulomatous disease consistent with sarcoidosis
-Chest imaging (X-ray, CT) documenting pulmonary involvement and staging
-Pulmonary function tests (FVC, DLCO)
-Documentation of corticosteroid requirements and dosage
-Cardiac evaluation if cardiac involvement suspected
-Service records documenting occupational dust or chemical exposure
SECONDARY CONDITIONS (3 MAPPED)
DC 6817
Pulmonary sarcoidosis causes pulmonary hypertension in 5-15% of patients.
DC 7010
Cardiac sarcoidosis causes conduction abnormalities and arrhythmias.
DC 7508
Sarcoidosis causes hypercalcemia and nephrolithiasis through excessive vitamin D production.
C&P EXAM TIPS (4)
1.Document corticosteroid requirements specifically — dose (high vs. low) and frequency (continuous vs. intermittent) determine rating level.
2.Burn pit/airborne hazards exposure during deployment can establish service connection for sarcoidosis.
3.Request pulmonary function testing at C&P exam — FVC and DLCO document severity.
4.Cardiac sarcoidosis rates under cardiovascular codes — file separately if cardiac involvement present.
RELEVANT CASE LAW
38 C.F.R. § 3.317 — Undiagnosed Illness
Sarcoidosis in Gulf War veterans may qualify under undiagnosed/medically unexplained illness provisions if direct nexus cannot be established.
DOLLAR IMPACT
10% stable disease: $175.03/mo. 30% maintenance steroids: $524.31/mo. 60% high-dose steroid dependence: $1,131.68/mo. Cardiac or severe pulmonary sarcoidosis: 100% = $3,938.58/mo.
EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026